- Home
- PLX vs DOUG Comparison
PLX vs DOUG Comparison
Compare PLX & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLX | DOUG |
|---|---|---|
| Founded | 1993 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.4M | 162.3M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLX | DOUG |
|---|---|---|
| Price | $2.20 | $1.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 569.2K | 368.2K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.68 |
| EPS | ★ 0.22 | N/A |
| Revenue | $52,744,000.00 | ★ $955,578,000.00 |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.18 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.34 | $1.53 |
| 52 Week High | $3.19 | $3.19 |
Technical Indicators
Market Signals| Indicator | PLX | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 62.05 | 45.33 |
| Support Level | $2.03 | $1.69 |
| Resistance Level | $2.42 | $1.86 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 98.93 | 20.00 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.